Status:
RECRUITING
Epidural Spinal Cord Stimulation for Lower-limb Impairment in Adrenomyeloneuropathy
Lead Sponsor:
Third Military Medical University
Collaborating Sponsors:
Beijing Tiantan Hospital
Jingmen No.1 People's Hospital
Conditions:
Adrenomyeloneuropathy Without Cerebral Involvement
Eligibility:
MALE
22-50 years
Phase:
NA
Brief Summary
Adrenal spinal neuropathy (AMN) is a rare X-linked genetic disease caused by mutations in the ABCD1 gene, and belongs to a special type of adrenal leukodystrophy. The patient's lower limb strength is ...
Detailed Description
Adrenomyeloneuropathy (AMN) is an X-linked inherited metabolic rare disease caused by mutations in the ABCD1 gene, with an incidence rate of only 1 in 50,000. Currently, it is regarded as a special ty...
Eligibility Criteria
Inclusion Criteria:
- Conforming to the diagnostic criteria of AMN, with a definite genetic testing report, and complicated by lower limb motor function disorders;
- Capable of normal communication and able to complete scale tests independently (as determined by on-site scale tests);
- Willing to participate in this study after giving informed consent;
- The muscle tone of the patient's bilateral lower extremities was elevated.
Exclusion Criteria:
- Other inherited diseases;
- Other severe central nervous system diseases;
- History of brain surgery;
- Psychiatric and psychological diseases such as depression and anxiety;
- The presence of metallic foreign bodies or prostheses (such as cardiac pacemakers, insulin pumps) in the body, claustrophobia, and other contraindications for MRI;
- Informed consent was not obtained;
- Unable to tolerate MRI-related examinations;
- Received anticoagulant, antispasmodic or antiepileptic drug therapies throughout the entire study period;
- Postoperative wound infection;
- Other motor disorders, spinal cord pathologies, fractures, osteoarthritis, amputations, scoliosis and other movement-affecting diseases.
Key Trial Info
Start Date :
February 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06796920
Start Date
February 10 2025
End Date
October 1 2027
Last Update
January 28 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing TianTan Hospital
Beijing, Beijing Municipality, China, 100070
2
The 958 Hospital of Chinese People's Liberation Army, The Jiangbei Campus of Southwest Hospital, The First Affiliated Hospital of Army Medical University
Chongqing, Chongqing Municipality, China, 400020
3
the Southwest hospital
Chongqing, Chongqing Municipality, China, 400038
4
Jingmen No.1 People's Hospital
Jingmen, Hubei, China, 448000